Active substance
LUMACAFTOR/IVACAFTOR
Therapeutical formulation
TABLETTEN EN CAPSULES

€ 94.98 € 10,638.03 excluding delivery costs.

This drug is fully reimbursed by your health insurance company.

Conditions apply to the reimbursement of this medicine.

Own risk

€ 94.98 € 10,638.03

This is the amount charged to your deductible per piece per package.

Strength
200/125MG
Supplier
ORIGINALIS B.V.
Available outside pharmacies
No
Remarks
  • This medicine is available by prescription only.
  • This drug is imported from {0).Ierland.
EU number
EU/1/15/1059/001

Conditions

Basic insurance

Lumacaftor/Ivacaftor Voorwaarde: uitsluitend voor cystische fibrose (CF) patienten van een jaar of ouder die homozygoot zijn voor de F508del-mutatie in het CFTR-gen.